Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector
Vaccines · 25.09.2025 · 13 (10) · 1006
DOI: 10.3390/vaccines13101006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 25.09.2025. Verfasst von Jae-Bang Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Optipharm Inc., Osong 28158, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Virus-like particle (VLP) vaccines based on human papillomavirus (HPV) L1 proteins have high efficacy for preventing cervical cancer and other HPV-associated diseases. The production yields of commercial HPV VLPs remain suboptimal. We aimed to improve HPV VLP production efficiency using a hyper-expression vector system for the expression of L1 proteins of four major HPV serotypes—HPV 6, 11, 16, and 18.
Methods
HPV L1 proteins were expressed in Trichoplusia ni (Hi5) insect cells via a hyper-expression baculovirus vector system. Following cell lysis using a microfluidizer, VLPs were purified through a two-step chromatographic process. Particle morphology was characterized using transmission electron microscopy and dynamic light scattering. Immunogenicity was evaluated using a murine model; mice received three intramuscular injections of the purified quadrivalent VLPs. The resulting IgG and neutralizing antibody responses were compared with those elicited by the commercial quadrivalent vaccine, Gardasil.
Results
The L1 proteins from HPV 6, 11, 16, and 18 were successfully expressed at high levels in Hi5 cells, forming uniformly sized VLPs with hydrodynamic diameters of 50–60 nm. The average production yield of the quadrivalent VLPs exceeded 40 mg/L, an improvement over conventional yields. The candidate VLPs elicited strong HPV-specific IgG and neutralizing antibody responses in mice, comparable to those induced by Gardasil.
Conclusions
The hyper-expression baculovirus vector system enables high-yield production of HPV L1 VLPs with desirable structural and immunogenic properties. This approach holds promise for the cost-effective and scalable manufacturing of next-generation HPV VLP vaccines, facilitating broader global access to HPV immunization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Optipharm Inc., Osong 28158, Republic of Korea.
- Department of Agricultural Biology, College of Agriculture, Life & Environment Science, Chungbuk National University, Cheongju 28644, Republic of Korea.
ORCID-Profile: Jae-Deog Kim, Soo-Dong Woo
Zitieren
APA
Choi, J. B., Lee, J. H., Kim, E. H., Kim, J. D., Kim, S. Y., Oh, J. M., Woo, S. D., Kim, H., & Han, B. K. (2025). Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector. Vaccines, 13(10), 1006. https://doi.org/10.3390/vaccines13101006
Vancouver
Choi JB, Lee JH, Kim EH, Kim JD, Kim SY, Oh JM, et al. Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector. Vaccines. 2025;13(10):1006. doi:10.3390/vaccines13101006
BibTeX
@article{Choi2025,
author = {Choi, Jae-Bang and Lee, Ji-Hoon and Kim, Eun-Ha and Kim, Jae-Deog and Kim, Seong-Yeong and Oh, Jong-Min and Woo, Soo-Dong and Kim, Hyunil and Han, Beom-Ku},
title = {Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {10},
pages = {1006},
doi = {10.3390/vaccines13101006}
}
EUVIMED